Skip to main content
TipRanks
Go Ultimate75% OFF

Invivyd (IVVD) Drug Pipeline

1,056 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Vyd2311-Sd, Vyd2311-MdCovid-19Phase IIIRecruitingStudy of VYD2311 for the Prevention of COVID-19Dec 18, 2025―
Vyd2311Covid-19Phase IActive Not RecruitingA Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy ParticipantsJul 18, 2024―
Normal Saline, Vyd222Covid-19, Sars-Cov-2Phase IIICompletedA Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2Sep 08, 2023―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Invivyd (IVVD) have in its pipeline
Invivyd IVVD is currently developing the following drugs: Vyd2311-Sd, Vyd2311-Md, Vyd2311, Normal Saline, Vyd222. These drug candidates are in various stages of clinical development as the company works toward FDA approval.